Latest News

Higher AFM24 Exposure Boosts Response in Advanced NSCLC: AACR Data
Higher AFM24 Exposure Boosts Response in Advanced NSCLC: AACR Data

May 2nd 2025

A post hoc analysis shows significantly improved ORR and PFS in advanced NSCLC with higher AFM24 exposure, supporting optimized dosing strategies.

FDA Clears Phase 1 Study of TGW101 for Advanced Solid Tumor Treatment
FDA Clears Phase 1 Study of TGW101 for Advanced Solid Tumor Treatment

April 24th 2025

Ivonescimab Plus Chemo Shows Stronger NSCLC Response Than Tislelizumab Combo
Ivonescimab Plus Chemo Shows Stronger NSCLC Response Than Tislelizumab Combo

April 23rd 2025

Leighl Covers PALOMA-3 Trial of SC Amivantamab in NSCLC
Leighl Covers PALOMA-3 Trial of SC Amivantamab in NSCLC

April 18th 2025

Novel Radioenhancer JNJ-1900 Shows Potential Across Cancers
Novel Radioenhancer JNJ-1900 Shows Potential Across Cancers

April 15th 2025

More News